Ilenia Calcaterra: RESOLVE Study on Hypertrophic Synovium in Severe Hemophilia A Under Emicizumab
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared a post on LinkedIn:
“Honored to have presented our work on hypertrophic synovium in severe haemophilia A during the moderated poster session at the WFH 2026 World Congress in Kuala Lumpur.
It was a real privilege to be among the candidates for the Christine Lee Young Researcher Award for best poster and to share this moment with such talented young researchers from around the world.
Our study, RESOLVE, focused on changes in hypertrophic synovium in adult patients with severe haemophilia A receiving emicizumab prophylaxis.
The data suggest that while emicizumab provides excellent bleed control, meaningful improvement in synovial status can also be observed, reinforcing the importance of joint monitoring and individualized joint health management.
Grateful for this opportunity, for the scientific exchange, and for the chance to contribute to ongoing research in haemophilia care.”
Find more posts featuring Ilenia Calcaterra on Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy